This is the story of how a change in marketing strategy completely transformed the fortunes of Sensodyne. Formerly a small player in a niche category, Sensodyne is now a $1bn brand, in a category it ...

This is the story of how a change in marketing strategy completely transformed the fortunes of Sensodyne. Formerly a small player in a niche category, Sensodyne is now a $1bn brand, in a category it ...

An estimated 20 percent of the world’s population has some form of enhanced sensitivity to environmental or emotional stimuli ...

(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner ...

Shares in the maker of Sensodyne, Panadol and Advil, which gained 17% in 2024, were up 0.7% at 369.7 pence in morning trade on Wednesday, in line with the broader FTSE 100 (.FTSE), opens new tab.

Haleon, recognized for brands like Sensodyne and Advil, emerged from a merger between Pfizer’s and GSK Plc’s (NYSE:GSK) consumer healthcare divisions in 2019, with Pfizer holding a significant ...